DSM at a glance

Overview of our business & performance

A broad, global health and nutrition business

DSM is a global purpose-led, science-based company founded in 1902 and listed on Euronext Amsterdam. We are a leader in health, nutrition and bioscience which, through our products and solutions, aims to address some of the world’s biggest challenges whilst creating profitable growth in order to simultaneously deliver economic, environmental and societal value for all.

2022 key data

Group

€8,390m

Net sales

€7,269 in 2021

€1,395m

Adjusted EBITDA

€1,379 in 2021

16.6%

Adjusted EBITDA margin

19.0% in 2021

Health, Nutrition & Bioscience

€8,319m

Net sales

€7,166 in 2021

€1,490m

Adjusted EBITDA

€1,467 in 2021

17.9%

Adjusted EBITDA margin

20.5% in 2021

People

0.28

Frequency Index of Recordable Injuries

0.22 in 2021

77%

Employee Engagement Index

77% in 2021

26%

Female executives

23% in 2021

Planet

35%

Absolute reduction

Scope 1 + 2 GHG emissions (2016 baseline)

~26%

Structural improvement

Scope 1 + 2 GHG emissions (2016 baseline)

17%

Intensity improvement

Scope 3 GHG emissions (2016 baseline)

Profit

↑1%

Adjusted EBITDA

continuing operations vs. 2021

€310m

Adjusted net operating free cash flow

€555m

Net profit from continuing operations

Latest financial & regulatory news

  • DSM - delivery of shares

    28 Apr 2023

    Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

  • DSM - delivery of shares

    26 Apr 2023

    Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Managing Board

Geraldine Matchett, Co-CEO

Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014. 

Dimitri de Vreeze, Co-CEO

Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013. 

Read more

  • Factbooks

    Factbooks

    DSM's Factbook provides investors and analysts with an introduction to the company and our key individual businesses.